Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 14, 2020; 26(30): 4501-4522
Published online Aug 14, 2020. doi: 10.3748/wjg.v26.i30.4501
Figure 7
Figure 7 Changes in Knodell histological activity index score, Ishak fibrosis score, liver hepatitis B surface antigen levels and liver hepatitis B core antigen levels at 96 wk after administration in the two groups. A: Knodell histological activity index score; B: Ishak fibrosis score; C: Liver hepatitis B surface antigen levels; D: Liver hepatitis B core antigen levels. HAI: Histological activity index; HBsAg: Hepatitis B surface antigen; HBcAg: Hepatitis B core antigen.

  • Citation: Xing YF, Wei CS, Zhou TR, Huang DP, Zhong WC, Chen B, Jin H, Hu XY, Yang ZY, He Q, Jiang KP, Jiang JM, Hu ZB, Deng X, Yang F, Li FY, Zhao G, Wang LC, Mi YQ, Gong ZJ, Guo P, Wu JH, Shi WQ, Yang HZ, Zhou DQ, Tong GD. Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients. World J Gastroenterol 2020; 26(30): 4501-4522
  • URL: https://www.wjgnet.com/1007-9327/full/v26/i30/4501.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v26.i30.4501